IN SILICO STUDY OF BIOACTIVE PEPTIDES AS SARS COV-2 PROTEASE INHIBITORS
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) emerged in 2019 in Wuhan, China, and has since caused a global pandemic known as COVID-19. In 2024, the World Health Organization tracked several new variants of SARS CoV2 that could potentially evade immune responses and increase transm...
Saved in:
Main Author: | Iqbal Rhamadianto, Muhamad |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/85519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
Phylogenetic network analysis of SARS-CoV-2 Mpro protease and the in silico screening of bioactive compounds from Philippine medicinal plants as potential Mpro inhibitors
by: Villanueva, Jose Antonio B.
Published: (2021) -
Solanaceae Family Phytochemicals as Inhibitors of 3C-Like Protease of SARS-CoV-2: An In Silico Analysis
by: Mahmood R.A.
Published: (2023) -
In Silico Study of Entry Inhibitor from Moringa oleifera Bioactive Compounds against SARS-CoV-2 Infection
by: Mawaddani, Nala, et al.
Published: (2022) -
Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
by: Bodee Nutho, et al.
Published: (2022) -
Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
by: Nutho B.
Published: (2023)